{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:30:27Z","timestamp":1759336227295,"version":"3.33.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.ejphar.2007.06.046","type":"journal-article","created":{"date-parts":[[2007,7,5]],"date-time":"2007-07-05T11:16:35Z","timestamp":1183634195000},"page":"100-110","source":"Crossref","is-referenced-by-count":15,"title":["Deprenyl treatment attenuates long-term pre- and post-synaptic changes evoked by chronic methamphetamine"],"prefix":"10.1016","volume":"573","author":[{"given":"Colin","family":"Davidson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuwn","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everett H","family":"Ellinwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.06.046_bib1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1471-4159.2002.00994.x","article-title":"Increase in glutamate induced neurotoxicity by activated astrocytes involves stimulation of protein kinase C","volume":"82","author":"Ahlemeyer","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.06.046_bib2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.biopsych.2004.08.019","article-title":"Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions","volume":"57","author":"Arnsten","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.06.046_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0143-4160(03)00141-6","article-title":"Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity","volume":"34","author":"Arundine","year":"2003","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ejphar.2007.06.046_bib4","first-page":"245","article-title":"Hyperpyrexia as a contributing factor in the toxicity of amphetamine in aggregated mice","volume":"19","author":"Askew","year":"1962","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.ejphar.2007.06.046_bib5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0893-133X(98)00092-X","article-title":"Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoria","volume":"20","author":"Bartzokis","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.06.046_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2007.06.046_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1098-2396(199710)27:2<153::AID-SYN6>3.0.CO;2-D","article-title":"Methamphetamine selectively damages dopaminergic innervation to the nucleus accumbens core while sparing the shell","volume":"27","author":"Broening","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2007.06.046_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-3806(97)81791-9","article-title":"Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response","volume":"103","author":"Cappon","year":"1997","journal-title":"Dev. Brain Res."},{"key":"10.1016\/j.ejphar.2007.06.046_bib9","first-page":"370","article-title":"CP-101606 Pfizer Inc","volume":"1","author":"Chazot","year":"2000","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.ejphar.2007.06.046_bib10","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","article-title":"Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin","volume":"72","author":"Chen","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.06.046_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1098-2396(200102)39:2<161::AID-SYN7>3.0.CO;2-E","article-title":"Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse","volume":"39","author":"Cho","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2007.06.046_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF03033383","article-title":"Studies on neuronal apoptosis in primary forebrain cultures: neuroprotective\/anti-apoptotic action of NR2B NMDA antagonists","volume":"5","author":"Dave","year":"2003","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2007.06.046_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(01)00054-6","article-title":"Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment","volume":"36","author":"Davidson","year":"2001","journal-title":"Brains Res. Rev."},{"key":"10.1016\/j.ejphar.2007.06.046_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuint.2004.11.004","article-title":"Acute and chronic continuous methamphetamine have different long-term behavioral and neurochemical consequences","volume":"46","author":"Davidson","year":"2005","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2007.06.046_bib15","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1073\/pnas.96.6.3269","article-title":"Ca2+\/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors","volume":"96","author":"Derkach","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2007.06.046_bib17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1523\/JNEUROSCI.16-01-00274.1996","article-title":"Drugs of abuse and stress increase the expression of gluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptation among cross-sensitizing agents","volume":"16","author":"Fitzgerald","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.06.046_bib18","first-page":"696","article-title":"Expression of NMDA neuroreceptors in experimental ischemia","volume":"68","author":"Gappoeva","year":"2003","journal-title":"Biochem. Russ."},{"key":"10.1016\/j.ejphar.2007.06.046_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0166-2236(03)00065-1","article-title":"It could be habit forming: drugs of abuse and striatal synaptic plasticity","volume":"26","author":"Gerdeman","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2007.06.046_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0376-8716(95)01137-N","article-title":"Absence of acute cocaine interactions with the MAO-B inhibitor selegiline","volume":"39","author":"Haberny","year":"1995","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2007.06.046_bib21","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1097\/01.ALC.0000093601.33119.E3","article-title":"The neurotoxicity induced by ethanol withdrawal in mature organotypic hippocampal slices might involve cross-talk between metabotropic glutamate type 5 receptors and N-methyl-d-aspartate receptors","volume":"27","author":"Harris","year":"2003","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2007.06.046_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1471-4159.2001.00396.x","article-title":"HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity","volume":"78","author":"Haughey","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.06.046_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2005.09.051","article-title":"Differential regulation of ionotropic glutamate receptor subunits following cocaine self-administration","volume":"1064","author":"Hemby","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.06.046_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.wnf.0000171248.89726.2f","article-title":"Remarkable effect of selegiline (l-deprenyl), a selective monoamine oxidase type-B inhibitor, in a patient with severe refractory depression: a case report","volume":"28","author":"Higuchi","year":"2005","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2007.06.046_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00213-003-1616-6","article-title":"Transdermal selegeline and intravenous cocaine: safety and interactions","volume":"172","author":"Houtsmuller","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2007.06.046_bib26","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1038\/sj.bjp.0703493","article-title":"Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig","volume":"130","author":"Ilani","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.046_bib27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.neuron.2005.02.005","article-title":"Unmanageable motivation in addiction: a path in prefrontal-accumbens glutamate transport","volume":"45","author":"Kalivas","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2007.06.046_bib28","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1006\/mcne.2001.0988","article-title":"High abundance of mGlu1 receptor mRNA and reduced Q\/R editing of GluR2 mRNA in individual NADPH-diaphorase neurons","volume":"17","author":"Kim","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2007.06.046_bib29","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0047-6374(01)00392-X","article-title":"Why (\u2212) deprenyl prolongs survivals of experimental animals: increase of anti-oxidant enzymes in brain and other body tissues as well as mobilization of various humoral factors may lead to systemic anti-aging effects","volume":"123","author":"Kitani","year":"2002","journal-title":"Mech. Ageing Develop."},{"key":"10.1016\/j.ejphar.2007.06.046_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0404.1989.tb01787.x","article-title":"The pharmacology of selegiline ((\u2212)deprenyl). New aspects","volume":"126","author":"Knoll","year":"1989","journal-title":"Acta. Neurol. Scand., Suppl."},{"key":"10.1016\/j.ejphar.2007.06.046_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0773.1998.tb01399.x","article-title":"(\u2212)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain","volume":"82","author":"Knoll","year":"1998","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2007.06.046_bib32","first-page":"1","article-title":"Multiple, small dose administration of (\u2212)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition","volume":"328","author":"Knoll","year":"1994","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejphar.2007.06.046_bib33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jnr.10189","article-title":"Chronic treatment with glutaric acid induces partial tolerance to excitotoxicity in neuronal cultures from chick embryo telencephalons","volume":"68","author":"Kolker","year":"2002","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.ejphar.2007.06.046_bib34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0006-8993(99)01363-3","article-title":"Trophic effects of selegiline on cultured dopaminergic neurons","volume":"829","author":"Kontkanen","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.06.046_bib35","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/35016089","article-title":"Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity","volume":"405","author":"Lee","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2007.06.046_bib36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1097-4547(19980715)53:2<235::AID-JNR12>3.0.CO;2-5","article-title":"l-deprenyl potentiates NGF-induced changes in superoxide dismutase mRNA in PC12 cells","volume":"53","author":"Li","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2007.06.046_bib37","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1046\/j.1471-4159.2000.0752040.x","article-title":"Regulation of NMDA receptor subunits and nitric oxide synthase expression during cocaine withdrawal","volume":"75","author":"Loftis","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.06.046_bib38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00213-002-1209-9","article-title":"Cocaine treatment- and withdrawal-induced alterations in the expression and serine phosphorylation of the NR1 NMDA receptor subunit","volume":"164","author":"Loftis","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2007.06.046_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7258(02)00302-9","article-title":"The N-methyl-d-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications","volume":"97","author":"Loftis","year":"2003","journal-title":"Pharmacol. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2007.06.046_bib40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuropharm.2004.06.027","article-title":"Incubation of cocaine craving after withdrawal: a review of preclinical data","volume":"47","author":"Lu","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2007.06.046_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0031-9384(85)90176-3","article-title":"Effects of dopamine agonists on hypothalamic defensive attack in cats","volume":"35","author":"Maeda","year":"1985","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2007.06.046_bib42","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.2174\/0929867043364793","article-title":"Pharmacological aspects of (\u2212)-deprenyl","volume":"11","author":"Magyar","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.06.046_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archpsyc.1989.01810010047007","article-title":"A controlled study of the antidepressant efficacy and side effects of (\u2212)-deprenyl. A selective monoamine oxidase inhibitor","volume":"46","author":"Mann","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.06.046_bib44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0892-0362(02)00221-0","article-title":"Neuroprotection by propargylamines in Parkinson's disease: suppression of apoptosis and induction of prosurvival genes","volume":"24","author":"Maruyama","year":"2002","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.ejphar.2007.06.046_bib45","first-page":"90","article-title":"Pharmacokinetic and pharmacodynamic analysis of the actions of d-amphetamine and d-methamphetamine on the dopamine terminal","volume":"274","author":"Melega","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.06.046_bib46","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1006\/bbrc.2000.4037","article-title":"Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes","volume":"279","author":"Mizuta","year":"2000","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"10.1016\/j.ejphar.2007.06.046_bib47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1254\/jphs.FPJ04040X","article-title":"Effects of dopamine- and serotonin-related compounds on methamphetamine-induced self-injurious behavior in mice","volume":"96","author":"Mori","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2007.06.046_bib48","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00221-002-1039-3","article-title":"Enhancement of N-methyl-d-aspartate receptor-mediated excitatory potentials in the neostriatum after methamphetamine sensitization","volume":"144","author":"Moriguchi","year":"2002","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.ejphar.2007.06.046_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0197-0186(03)00100-1","article-title":"NR2B subunit selective NMDA antagonists inhibit neurotoxic effect of alcohol-withdrawal in primary cultures of rat cortical neurones","volume":"44","author":"Nagy","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2007.06.046_bib50","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1074\/jbc.M008085200","article-title":"Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR2 (NR2B) subunit of the N-methyl-d-aspartate receptor","volume":"276","author":"Nakazawa","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2007.06.046_bib51","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/clpt.1994.206","article-title":"Evaluation of physical dependence liability of l-deprenyl (selegiline) in animals","volume":"56","author":"Nickel","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.06.046_bib52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(99)00386-9","article-title":"Expression of long-term potentiation of the striatum in methamphetamine-sensitized rats","volume":"268","author":"Nishioku","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2007.06.046_bib53","first-page":"863","article-title":"Investigating potential anxiolytic, antidepressant and memory enhancing activity of deprenyl","volume":"52","author":"Nowakowska","year":"2001","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.046_bib54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0197-0186(95)00152-2","article-title":"The role of glutamate in behavioral and neurotoxic effects of methamphetamine","volume":"29","author":"Ohmori","year":"1996","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2007.06.046_bib55","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0006-8993(00)03084-5","article-title":"Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats","volume":"890","author":"Palmer","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.06.046_bib56","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00335-004-2451-8","article-title":"Gene expression differences in mice divergently selected for methamphetamine sensitivity","volume":"16","author":"Palmer","year":"2005","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.ejphar.2007.06.046_bib57","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1054-3589(08)60752-8","article-title":"Antiapoptotic actions of monoamine oxidase B inhibitors","volume":"42","author":"Paterson","year":"1998","journal-title":"Adv. Pharmacol."},{"year":"1986","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","key":"10.1016\/j.ejphar.2007.06.046_bib58"},{"key":"10.1016\/j.ejphar.2007.06.046_bib59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0014-2999(01)01592-8","article-title":"Tolerance to the neurotoxic effects of methamphetamine in young rats","volume":"435","author":"Riddle","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.046_bib60","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0022-3565(24)35230-9","article-title":"Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat","volume":"291","author":"Riviere","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.06.046_bib61","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/cne.20717","article-title":"Chemistry of the mind: neurochemical modulation of prefrontal cortical function","volume":"493","author":"Robbins","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2007.06.046_bib62","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0896-6273(00)80144-0","article-title":"Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit","volume":"16","author":"Roche","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2007.06.046_bib63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/syn.10183","article-title":"Selegiline potentiates cocaine-induced increases in rodent nucleus accumbens dopamine","volume":"48","author":"Schiffer","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2007.06.046_bib64","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/clpt.1994.205","article-title":"Therapy with l-deprenyl (selegiline) and relation to abuse liability","volume":"56","author":"Schneider","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.06.046_bib65","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0166-2236(93)90093-2","article-title":"The molecular biology of mammalian glutamate receptor channels","volume":"16","author":"Seeburg","year":"1993","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2007.06.046_bib66","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/sj.npp.1300247","article-title":"Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge","volume":"28","author":"Segal","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.06.046_bib67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(96)00593-6","article-title":"Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage","volume":"315","author":"Semkova","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.046_bib68","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1177\/009127009603601109","article-title":"Chronopharmacokinetics and chronopharmacodynamics of dextromethamphetamine in man","volume":"36","author":"Shappell","year":"1996","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.046_bib69","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1016\/S0024-3205(03)00191-7","article-title":"Enhancer substances: selegiline and R-(\u2212)-1-(benzofuran-2-yl)-2-propylaminopentane [(\u2212)-BPAP] enhance the neurotrophic factor synthesis on cultured mouse astrocytes","volume":"72","author":"Shimazu","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2007.06.046_bib70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(75)90040-0","article-title":"Effects of psychotropic drugs on methamphetamine-induced behavioral excitation in grouped mice","volume":"31","author":"Shintomi","year":"1975","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.046_bib71","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/154596830101500305","article-title":"Selegiline treatment facilitates recovery after stroke","volume":"15","author":"Sivenius","year":"2001","journal-title":"Neurorehab. Neur. Rep."},{"key":"10.1016\/j.ejphar.2007.06.046_bib72","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1523\/JNEUROSCI.20-12-04480.2000","article-title":"Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo","volume":"20","author":"Snyder","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.06.046_bib73","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0006-8993(96)00995-X","article-title":"Treatment of mice with methamphetamine produces cell loss in the substantia nigra","volume":"738","author":"Sonsalla","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.06.046_bib74","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/syn.890170310","article-title":"Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux","volume":"17","author":"Stephens","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2007.06.046_bib75","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.1523\/JNEUROSCI.4603-04.2005","article-title":"Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons","volume":"25","author":"Sun","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.06.046_bib76","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-2999(02)02729-2","article-title":"Protective effects of selegiline and desmethylselegiline against N-methyl-d-aspartate-induced rat retinal damage","volume":"458","author":"Takahata","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.046_bib77","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/(SICI)1097-4547(19980901)53:5<593::AID-JNR9>3.0.CO;2-4","article-title":"Enhanced glial cell line derived neurotrophic factor mRNA expression upon (\u2212)-deprenyl and melatonin treatments","volume":"53","author":"Tang","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2007.06.046_bib78","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00210-001-0492-z","article-title":"Effect of repeated treatment with high doses of selegiline on behaviour, striatal dopaminergic transmission and tyrosine hydroxylase mRNA levels","volume":"365","author":"Themann","year":"2002","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.046_bib79","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00435308","article-title":"The effect of deprenyl, a selective monoamine oxidase B inhibitor, on sleep and mood in man","volume":"70","author":"Thornton","year":"1980","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2007.06.046_bib80","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0361-9230(99)00030-1","article-title":"Region-specific alterations in the concentrations of catecholamines and indoleamines in the brains of young and old F344 rats after l-deprenyl treatment","volume":"48","author":"ThyagaRajan","year":"1999","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2007.06.046_bib81","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/35079077","article-title":"Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons","volume":"411","author":"Ungless","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2007.06.046_bib82","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1017\/S0317167100041524","article-title":"Deprenyl in Parkinson's disease: mechanisms, neuroprotective effect, indications and adverse effects","volume":"19","author":"Vezina","year":"1992","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2007.06.046_bib83","first-page":"47","article-title":"Metabolic studies of drugs of abuse","volume":"105","author":"Volkow","year":"1991","journal-title":"NIDA Res. Monogr"},{"key":"10.1016\/j.ejphar.2007.06.046_bib84","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/clpt.1994.208","article-title":"Intravenous self-administration studies with l-deprenyl (selegiline) in monkeys","volume":"56","author":"Winger","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.06.046_bib85","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0006-2952(99)00208-7","article-title":"l-Deprenyl, blocking apoptosis and regulating gene expression in cultured retinal neurons","volume":"58","author":"Xu","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.046_bib86","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1749-6632.2001.tb03560.x","article-title":"Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions","volume":"937","author":"Zhang","year":"2001","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2007.06.046_bib87","article-title":"Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors","author":"Zhang","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.06.046_bib88","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.neuron.2005.08.014","article-title":"Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory","volume":"47","author":"Zhao","year":"2005","journal-title":"Neuron"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907007625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907007625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T05:52:59Z","timestamp":1737179579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299907007625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":87,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0014299907007625"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.06.046","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}